CHEMOTHERAPY OF NON-IRRADIATED MALIGNANT GLIOMAS - PHASE-II - STUDY OF THE COMBINATION OF METHYL-CCNU, VINCRISTINE, AND PROCARBAZINE

被引：0
|
作者：
AVELLANOSA, AM
WEST, CR
TSUKADA, Y
HIGBY, DJ
BAKSHI, S
REESE, PA
JENNINGS, E
机构：
[1] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT NEUROSURG,BUFFALO,NY 14263
[2] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT PATHOL,BUFFALO,NY 14263
[3] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT MED A,BUFFALO,NY 14263
[4] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,CTR COMP,BUFFALO,NY 14263
[5] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT DIAGNOST RADIOL,BUFFALO,NY 14263
[6] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT NUCL MED,BUFFALO,NY 14263
来源：
CANCER | 1979年 / 44卷 / 03期
关键词：
D O I：
10.1002/1097-0142(197909)44:3<839::AID-CNCR2820440308>3.0.CO;2-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：839 / 846
页数：8
相关论文
共 50 条
  • [21] COMBINATION CHEMOTHERAPY OF DISSEMINATED GI ADENOCARCINOMA WITH VINCRISTINE (VCR), METHYL-CCNU, AND 5-FLUOROURACIL (5-FU)
    STONE, LA
    HOELTGEN, TM
    PERLIA, CP
    WOLTER, J
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 326 - 326
  • [22] PHASE-II STUDY OF MITOMYCIN, METHOTREXATE, AND VINCRISTINE COMBINATION CHEMOTHERAPY IN ADVANCED ADENOCARCINOMA OF THE LUNG
    SHAH, A
    KLIMO, P
    MURRAY, N
    CANCER TREATMENT REPORTS, 1984, 68 (10): : 1299 - 1300
  • [23] 5-YEAR SURVIVAL OF NON-IRRADIATED MALIGNANT GLIOMAS TREATED WITH CHEMOTHERAPY ALONE
    AVELLANOSA, AM
    WEST, CR
    MADAJEWICZ, S
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 531 - 531
  • [24] PHASE I-II STUDY OF COMBINATION CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE (CTX) AND METHYL CCNU
    MURPHY, WK
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 253 - 253
  • [25] A PHASE-II STUDY WITH RADIOFREQUENCY HYPERTHERMIA (HT), RADIATION (RT), AND CHEMOTHERAPY (CT) WITH 5-FU AND METHYL-CCNU (MECCNU) IN CARCINOMAS OF THE PANCREAS AND STOMACH
    KHANDEKAR, JD
    SCANLON, EF
    GARCES, RM
    PRASAD, G
    LAWRENCE, GA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 155 - 155
  • [26] SURVIVAL RESPONSE OF MALIGNANT GLIOMAS TO RADIOTHERAPY WITH OR WITHOUT BCNU OR METHYL-CCNU CHEMOTHERAPY AT THE UNIVERSITY-OF-KENTUCKY MEDICAL-CENTER
    CHIN, HW
    YOUNG, AB
    MARUYAMA, Y
    CANCER TREATMENT REPORTS, 1981, 65 (1-2): : 45 - 51
  • [27] A PHASE-II STUDY OF VINCRISTINE IN MALIGNANT MESOTHELIOMA - A NEGATIVE REPORT
    MARTENSSON, G
    SORENSON, S
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 24 (02) : 133 - 134
  • [28] A PHASE-II STUDY OF CCNU WITH BENZNIDAZOLE FOR METASTATIC MALIGNANT-MELANOMA
    BLEEHEN, NM
    ROBERTS, JT
    NEWMAN, HFV
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1986, 12 (08): : 1401 - 1403
  • [29] PHASE II STUDY OF EFFECT OF METHYL-CCNU (NSC-95441) ON BRONCHOGENIC CARCINOMA
    TAKITA, H
    BRUGAROLAS, A
    MITTELMAN, A
    VINCENT, R
    CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1973, 4 (02): : 257 - 259
  • [30] RANDOMIZED PROSPECTIVE PHASE-III TRIAL OF METHYL-CCNU (NSC-95441) ALONE VERSUS METHYL-CCNU PLUS VINCRISTINE (NSC-67574) IN TREATMENT OF PATIENTS WITH METASTATIC MALIGNANT-MELANOMA
    BELLET, RE
    MASTRANGELO, MJ
    BERD, D
    LUSTBADER, E
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 284 - 284
12345